Navigation Links
Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
Date:6/27/2012

NEW YORK, June 27, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence

http://www.reportlinker.com/p0910372/Buyer-Spend-Activity-and-Procurement-Behaviors-and-Strategies-in-the-Pharmaceutical-Industry----2012-2013--Survey-Intelligence.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceu

Synopsis

  • Analysis of opinions drawn from leading pharmaceutical industry executives.
  • Analysis on how procurement expenditure, business strategies and practices in the pharmaceutical industry are set to change in 2011-2012.
  • Analysis on spending plans, budget allocations, challenges and investment opportunities of purchase decision makers.

Summary

This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading pharmaceutical industry executives. It analyzes how procurement expenditure, business strategies and practices are set to change in the pharmaceutical industry in 2012-13. This report gives you access to the category-level spending outlooks, budgets, supplier selection criteria, business challenges and investment opportunities for leading purchase decision makers. The report also identifies future growth of buyers and suppliers and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

Scope

  • The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
  • The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
  • The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
  • Key topics covered include buyer expenditure activity, procurement behaviors and strategies, threats and opportunities, economic outlook and business confidence.
  • In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats.
  • The report examines current practices and provides future expectations for the industry over the next 12-24 months.

Reasons To Buy

  • This report will help you to drive revenues by understanding future product investment areas and growth regions.
  • This report will help you to formulate effective sales and marketing strategies by identifying how buyer budgets are changing and the direction of spend in the future.
  • This report will help you to better promote your business by aligning your capabilities and business practices with your customer's changing needs.
  • This report will help you to secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.
  • This report will help you to predict how the industry will grow, consolidate and where it will stagnate.
  • This report will help you to uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.

Table of Contents

1 Introduction

1.1 What is This Report About?

1.2 Definitions

1.3 Methodology

1.4 Profile of Survey Respondents: Global Pharmaceutical Industry

1.4.1 Profile of buyer respondents: global pharmaceutical industry

1.4.2 Profile of supplier respondents: global pharmaceutical industry

2 Executive Summary

3 Global Pharmaceutical Industry Buyer Spend Activity

3.1 Global Pharmaceutical Industry: Annual Procurement Budgets

3.1.1 Global pharmaceutical industry: annual procurement budgets by company type

3.1.2 Global pharmaceutical industry: annual procurement budgets by region

3.1.3 Global pharmaceutical industry: annual procurement budgets by company turnover

3.2 Global Pharmaceutical Industry: Planned Change in Procurement Spend

3.2.1 Global pharmaceutical industry: planned change in procurement spend by buyer type

3.2.2 Global pharmaceutical industry: planned change in procurement spend by region

3.2.3 Global pharmaceutical industry: planned change in procurement spend by company turnover

3.2.4 Global pharmaceutical industry: planned change in expenditure vs. revenue growth optimism

3.2.5 Global pharmaceutical industry: planned change in expenditure vs. cost containment

3.2.6 Global pharmaceutical industry: planned change in procurement spend - cross industry comparisons

3.3 Planned change in procurement spend by product and service category

3.3.1 Planned change in procurement spend by product and service category - region

3.3.2 Planned change in procurement spend by product and service category - company turnover

3.4 Global Pharmaceutical Industry: Variations in Regional Supplier Prices

3.4.1 Global pharmaceutical industry: variations in regional supplier prices by company type

3.4.2 Global pharmaceutical industry: variations in supplier prices by region

3.4.3 Global pharmaceutical industry: variations in regional supplier prices by company turnover

4 Global Pharmaceutical Industry:Procurement Behaviors and Strategies

4.1 Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection

4.1.1 Global pharmaceutical industry: Critical success factors by company type

4.2 Future Procurement Objectives in the Global Pharmaceutical Industry

4.2.1 Future procurement objectives in the global pharmaceutical industry by company type

4.2.2 Future procurement objectives in the global pharmaceutical industry by region

4.2.3 Future procurement objectives in the global pharmaceutical industry by company turnover

4.3 E-procurement in the Global Pharmaceutical Industry

4.3.1 E-procurement in the global pharmaceutical industry by company type

4.3.2 E-procurement in the global pharmaceutical industry by region

4.3.3 E-procurement in the global pharmaceutical industry by company turnover

5 Appendix

5.1 Global Pharmaceutical Industry Survey Results - Closed Questions

5.2 Methodology

5.3 Contact us

5.4 About ICD Research

5.5 Disclaimer

List of Tables

Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012

Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012

Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012

Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012

Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012

Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012

Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012

Table 8: Annual Procurement Budgets: Global Pharmaceutical Industry Buyers in US$ (%), 2010-2012

Table 9: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Company (%), 2012

Table 10: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Region (%), 2012

Table 11: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Turnover (%), 2012

Table 12: Change in Total Procurement Expenditure of Global Pharmaceutical Industry Buyers (%), 2010-2012

Table 13: Global Pharmaceutical Industry: Change in Total Procurement Expenditure by Company Type (%), 2012

Table 14: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Region (%), 2012

Table 15: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Turnover (%), 2012

Table 16: Global Pharmaceutical Industry: Change in Expenditure vs. Revenue Growth (%), 2012

Table 17: Global Pharmaceutical Industry: Change in Expenditure vs. Cost Containment (%), 2012

Table 18: Planned Change in Procurement Spend: Cross Industry Comparison (%), 2012

Table 19: Global Pharmaceutical Industry Manufacturers: Change in Expenditure by Products and Services (%), 2012

Table 20: Global Pharmaceutical Industry CRO and CMO: Change in Expenditure by Products and Services (%), 2012

Table 21: Global Pharmaceutical Industry: Variations in Regional Supplier Prices (%), 2012

Table 22: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Company (%), 2012

Table 23: Global Pharmaceutical Industry: Variations in Supplier Prices by Region (%), 2012

Table 24: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Turnover (%), 2012

Table 25: Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection - Buyers vs. Suppliers, 2012

Table 26: Critical Success Factors for Supplier Selection - All Global Pharmaceutical Industry Buyers, 2012

Table 27: Global Pharmaceutical Industry: Future Procurement Objectives (%), 2012

Table 28: Global Pharmaceutical Industry: Future Procurement Objectives by Company (%), 2012

Table 29: Global Pharmaceutical Industry: Future Procurement Objectives by Region (%), 2012

Table 30: Global Pharmaceutical Industry: Future Procurement Objectives by Turnover (%), 2012

Table 31: E-Procurement in the Global Pharmaceutical Industry(%), 2012

Table 32: E-Procurement in the Global Pharmaceutical Industry: by Company (%), 2012

Table 33: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2012

Table 34: E-Procurement in the Global Pharmaceutical Industry by Turnover (%), 2012

Table 35: Survey Results - Closed Questions

List of Figures

Figure 1: Annual Procurement Budgets: Global Pharmaceutical Industry Buyers in US$ (%), 2010-2012

Figure 2: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Company (%), 2012

Figure 3: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Region (%), 2012

Figure 4: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Turnover (%), 2012

Figure 5: Change in Total Procurement Expenditure of Global Pharmaceutical Industry Buyers (%), 2010-2012

Figure 6: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Type (%), 2012

Figure 7: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Region (%), 2012

Figure 8: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Turnover (%), 2012

Figure 9: Global Pharmaceutical Industry Manufacturers: Change in Expenditure by Products and Services (%), 2012

Figure 10: Global Pharmaceutical Industry CRO and CMO: Change in Expenditure by Products and Services (%), 2012

Figure 11: Global Pharmaceutical Industry: Increase in Expenditure on Products and Services by Region (%), 2012

Figure 12: Global Pharmaceutical Industry: Increase in Expenditure on Products and Services by Turnover (%), 2012

Figure 13: Global Pharmaceutical Industry: Variations in Regional Supplier Prices (%), 2012

Figure 14: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Company (%), 2012

Figure 15: Global Pharmaceutical Industry: Variations in Supplier Prices by Region (%), 2012

Figure 16: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Turnover (%), 2012

Figure 17: Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection - Buyers vs. Suppliers, 2012

Figure 18: Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection - Buyers vs. Suppliers, 2012

Figure 19: Critical Success Factors for Supplier Selection - All Global Pharmaceutical Industry Buyers, 2012

Figure 20: Global Pharmaceutical Industry: Future Procurement Objectives (%), 2012

Figure 21: Global Pharmaceutical Industry: Future Procurement Objectives by Company (%), 2012

Figure 22: Global Pharmaceutical Industry: Future Procurement Objectives by Region (%), 2012

Figure 23: Global Pharmaceutical Industry: Future Procurement Objectives by Turnover (%), 2012

Figure 24: E-Procurement in the Global Pharmaceutical Industry:(%), 2012

Figure 25: E-Procurement in the Global Pharmaceutical Industry: by Company (%), 2012

Figure 26: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2012

Figure 27: E-Procurement in the Global Pharmaceutical Industry: by Turnover (%), 2012

To order this report:

Pharmaceutical Industry: Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence

More  Market Research Report

Check our  Industry Analysis and Insights

__________________________

Contact Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry
2. Global Pharmaceutical Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry
3. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
4. Supplier Marketing Spend Activity, Marketing and Sales Behaviors and Strategies in the Medical Devices Industry - 2012-2013 : Survey Intelligence
5. Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
6. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
7. K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity
8. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
9. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
10. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
11. Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):